These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 81800)

  • 1. Myelin basic protein serum factor (MBP-SF) in adult Lewis rats: a method for detection and evidence that MBP-SF influences the appearance of antibody to MBP in animals developing experimental allergic encephalomyelitis.
    Day ED; Varitek VA; Paterson PY
    Immunochemistry; 1978 Jul; 15(7):437-42. PubMed ID: 81800
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats.
    Fujinami RS; Paterson PY; Day ED; Varitek VA
    J Exp Med; 1978 Dec; 148(6):1716-21. PubMed ID: 82607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response against myelin antigens in two strains of rats with different susceptibility to experimental allergic encephalomyelitis (EAE).
    Rivero VE; Riera CM; Roth GA
    Autoimmunity; 1999; 29(2):129-37. PubMed ID: 10433074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tolerance in experimental autoimmune encephalomyelitis: serum and salivary antibody responses.
    Fuller KA; Pearl D; Whitacre CC
    J Neuroimmunol; 1990 Jun; 28(1):15-26. PubMed ID: 1692845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
    Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY; He B; Qiao J; Link H
    J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates.
    McKenna RM; Carter BG; Paterson JA; Sehon AH
    Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells.
    Gonatas NK; Howard JC
    Science; 1974 Nov; 186(4166):839-41. PubMed ID: 4143378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats.
    Strejan GH; Gilbert JJ; St Louis J
    Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
    Khoury SJ; Hancock WW; Weiner HL
    J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP.
    Hunter S
    Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Bitar DM; Whitacre CC
    Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire.
    Cao L; Sun D; Whitaker JN
    J Neuroimmunol; 1998 Aug; 88(1-2):21-9. PubMed ID: 9688320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form.
    Massacesi L; Vergelli M; Zehetbauer B; Liuzzi GM; Olivotto J; Ballerini C; Uccelli A; Mancardi L; Riccio P; Amaducci L
    J Neurol Sci; 1993 Oct; 119(1):91-8. PubMed ID: 7504090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of experimental allergic encephalomyelitis in the Lewis rat with activated spleen cells: differential activation with mitogens.
    Peters BA; Hinrichs DJ
    Cell Immunol; 1982 May; 69(1):175-85. PubMed ID: 6179635
    [No Abstract]   [Full Text] [Related]  

  • 19. Active immunization with complementary peptide PBM 9-1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats.
    Zhou SR; Whitaker JN
    J Neurosci Res; 1996 Aug; 45(4):439-46. PubMed ID: 8872904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.